AstraZeneca PLC Operating Cash Flow for the year ending December 31, 2024: USD 11.86 B

AstraZeneca PLC Operating Cash Flow is USD 11.86 B for the year ending December 31, 2024, a 14.65% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • AstraZeneca PLC Operating Cash Flow for the year ending December 31, 2023 was USD 10.35 B, a 5.48% change year over year.
  • AstraZeneca PLC Operating Cash Flow for the year ending December 31, 2022 was USD 9.81 B, a 64.48% change year over year.
  • AstraZeneca PLC Operating Cash Flow for the year ending December 31, 2021 was USD 5.96 B, a 24.26% change year over year.
  • AstraZeneca PLC Operating Cash Flow for the year ending December 31, 2020 was USD 4.80 B, a 61.64% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities